Byotrol investor relations
WebUK Investor Magazine — Byotrol announces £6.3m in sales & 2 post-period IP deals . ... Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, maximizing insights to identify, develop, formulate and commercialize cutting-edge antimicrobial technologies delivered in direct sales and in long-term ... WebByotrol plc has today announced a change of leadership, as Vivan Pinto has been promoted to Chief Executive Officer with immediate effect. David Traynor, who has been Byotrol’s Chief Executive Officer since 2014, moves into the new role of Executive Chairman. John Langlands, Byotrol’s Non-Executive Chairman since February 2024, …
Byotrol investor relations
Did you know?
WebInvestor Presentations. Documents available for download are in the Portable Document Format (PDF). In order to view the PDF files, you will need to have the free Adobe® … WebByotrol’s first antimicrobial technology was invented and patented. 2005. The company was floated on the UK AIM stock market. 2007. Byotrol Consumer Products set up in joint venture with Byotrol plc and WhatIf …
WebByotrol is dedicated to improving lives around the world by developing and commercialising market-leading, antimicrobial technologies and products. We endeavour to continually supply safe, efficacious products that are … WebByotrol – Leader in antimicrobial products & services +44 (0) 1925 742 000 Email [email protected] Working Hours Mon to Fri 09:00 - 17:00 OUR BRANDS Industry Sectors Animal Health Find out more Consumer Find …
Web-- Company Update -- Byotrol plc announces Interim Results for the six months ended 30 September 2024. Financial performance for the half year shows the results of an increasing focus on a... WebApr 12, 2024 · Byotrol plc (LON:BYOT) posted its quarterly earnings results on Thursday, December, 19th. The company reported ($0.15) earnings per share (EPS) for the quarter. Byotrol had a negative trailing twelve-month return on equity of 23.96% and a negative net margin of 33.57%.
WebNov 1, 2024 · Welcome to StarGroup InvestorRelations. Star Group, L.P. is a full-service energy provider specializing in the sale of home heating and air conditioning products and services to residential and commercial customers. The Company also services and sells heating and air conditioning equipment and for certain areas, provides plumbing services.
WebSep 1, 2024 · TIDMBYOT . RNS Number : 2599K . Byotrol PLC . 01 September 2024 . 1 September 2024 . Byotrol plc . INVESTOR PRESENTATION . Byotrol plc is pleased to announce that David Traynor CEO and Nic Hellyer CFO will provide a live presentation relating to the Group's results for the year ended 31 March 2024 via the Investor Meet … teoria de karl maxWebByotrol, Inc. * 2 Principals See who the company's key decision makers are 1 Contacts Reach the right people with access to detailed contact information. Corporate Relations Get the big picture on a company's affiliates and who they do business with. 4 See similar companies for insight and prospecting. Start Your Free Trial teoria de kohlbergWebJul 9, 2009 · Byotrol makes debut at VET Festival 2024 as hand hygiene partner - Byotrol Byotrol is pleased to announce that it will be exhibiting at VET Festival, the UK’s only outdoor veterinary conference at the beautiful Loseley Park, on 20th and 21st May 2024. teoria de kohlberg etapasWebDec 12, 2024 · Investor Presentation David Traynor, Executive Chairman, Vivan Pinto, CEO, and Chris Sedwell, CFO will provide a live presentation relating to these results via the Investor Meet Company platform on 14th Dec 2024 at 3:00pm GMT. The presentation is open to all existing and potential shareholders. teoria de kohlberg pdfWebFind company research, competitor information, contact details & financial data for Byotrol, Inc. of Spartanburg, SC. Get the latest business insights from Dun & Bradstreet. D&B … teoria de la burbujaWeb52 minutes ago · 1Q23 Financial highlights 1 See note 3 on slide 10 2 Represents the estimated Basel III common equity Tier 1 (“CET1”) capital and ratio and Total Loss-Absorbing Capacity for the current period. See note 1 on slide 11 3 Standardized risk-weighted assets (“RWA”). Estimated for the current period. See note 1 on slide 11 4 … teoria de lamarck darwin e neodarwinismoWeb2024 Full Year Results & Reports. Mayne Pharma 2024 Annual Report. FY21 Results Media Release. FY21 Results Presentation. teoría de kohlberg etapas